Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818
Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of…
Radioisotopes manufacturer SHINE Medical Technologies creates pharma unit
US radioisotopes manufacturer SHINE Medical Technologies has formed a new business division called SHINE Therapeutics in a move…
Agilent Technologies opens molecular spectroscopy hub in Oxfordshire
Agilent Technologies has opened a new facility for the research and development of molecular spectroscopy at the Harwell…
Agilent acquires BioTek Instruments for $1.16bn
Agilent acquisition of BioTek : US-based lab instrument manufacturer Agilent Technologies has wrapped up its previously announced $1.16…
Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US
Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in…
CMAB Biopharma, BJ Bioscience join forces for bi-functional antibody BJ-005
CMAB Biopharma (Suzhou), a pure-play biologics CDMO, and BJ Bioscience have signed an agreement for the development and…
Lilly bags Reyvow FDA approval for acute treatment of migraine
Reyvow FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug…
Galderma launches phase 3 atopic dermatitis trial for nemolizumab
Galderma, a Nestle-owned Swiss pharma company, said that it has enrolled the first patients in a phase 3…
Boehringer Ingelheim expands pets vaccines production facility in Athens
German pharma giant Boehringer Ingelheim has wrapped up the $76 million expansion of its pets vaccines production facility…
Novartis bags Beovu FDA approval for wet AMD
Beovu FDA approval for wet AMD : Swiss pharma giant Novartis has been given approval from the US…